Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicardipine and Esmolol in Coronary Artery Disease
NCT01171911Phase 4Unknown
- Sponsor
- Nanjing Medical University
- Start
- Oct 2010
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4 trial of nicardipine and esmolol in acute coronary syndrome (ACS) and coronary artery disease (CAD), sponsored by Nanjing Medical University. Primary endpoint: Endothelial shear stress assessed by computational fluid dynamics at 4 minutes. Status: unknown.
02
Drugs
nicardipineesmolol
03
Conditions
acute coronary syndrome (ACS)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01171911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171911.